Atlas Trials

An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder

Clinical trial NCT00269776 · COMPLETED

Trial details

NCT number
NCT00269776
Sponsor
Alza Corporation, DE, USA
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder
Start date
1998-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.